Last updated: February 5, 2024
Sponsor: Chinese University of Hong Kong
Overall Status: Trial Not Available
Phase
N/A
Condition
Breast Cancer
Cancer
Treatment
mammography
Clinical Study ID
NCT04156880
2019.629
Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women who had undergone standard mammography including craniocaudal (CC) andmediolateral oblique (MLO) views..
- Histopathology-proven diagnosis is available for patients with breast malignancy,including invasive breast cancer, carcinoma in situ, and borderline lesion et al.
- As reference standard of benign nature, results from pathology or clinical long-termfollow-up (>=2 years) examinations are available for cases without breast malignancy.
Exclusion
Exclusion Criteria:
- Patients with concurring lesions on mammograms that may influence subsequent AIpost-process.
- Patients without available pathologic diagnosis or long-term follow-up (>=2 years)examinations.
- Patients who had undergone breast surgical intervention (e.g. lumpectomy andmammoplasty) prior to first mammography.
- Patients diagnosed with other kinds of malignancy, concurrent with metastasis orinfiltration/invasion to breast.
Study Design
Treatment Group(s): 1
Primary Treatment: mammography
Phase:
Study Start date:
July 01, 2020
Estimated Completion Date:
December 31, 2023
Connect with a study center
The Chinese University of Hong Kong, Prince of Wale Hospital
Hong Kong, Shatin
Hong KongSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.